Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Modified resveratrol Longevinex improves endothelial function in adults with metabolic syndrome receiving standard treatment.

Fujitaka K, Otani H, Jo F, Jo H, Nomura E, Iwasaki M, Nishikawa M, Iwasaka T, Das DK.

Nutr Res. 2011 Nov;31(11):842-7. doi: 10.1016/j.nutres.2011.09.028.

PMID:
22118755
2.

Metformin improves endothelial function in patients with metabolic syndrome.

Vitale C, Mercuro G, Cornoldi A, Fini M, Volterrani M, Rosano GM.

J Intern Med. 2005 Sep;258(3):250-6.

3.

[Vascular dysfunction in metabolic disorders: evaluation of some therapeutic interventions].

Bouskela E, Kraemer de Aguiar LG, Nivoit P, Bahia LR, Villela NR, Bottino DA.

Bull Acad Natl Med. 2007 Mar;191(3):475-92; discussion 492-3. French.

PMID:
18072649
4.

Chlorthalidone improves endothelial-mediated vascular responses in hypertension complicated by nondiabetic metabolic syndrome.

Dell'Omo G, Penno G, Del Prato S, Pedrinelli R.

J Cardiovasc Pharmacol Ther. 2005 Dec;10(4):265-72.

PMID:
16382262
5.

Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

Esposito K, Ciotola M, Carleo D, Schisano B, Saccomanno F, Sasso FC, Cozzolino D, Assaloni R, Merante D, Ceriello A, Giugliano D.

Diabetes Care. 2006 May;29(5):1071-6.

PMID:
16644639
6.

The effect of moxonidine on endothelial dysfunction in metabolic syndrome.

Topal E, Cikim AS, Cikim K, Temel I, Ozdemir R.

Am J Cardiovasc Drugs. 2006;6(5):343-8.

PMID:
17083269
7.

Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.

de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, Bottino D, Bouskela E.

Diabetes Care. 2006 May;29(5):1083-9.

PMID:
16644641
8.

Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.

Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP.

Nutr Metab Cardiovasc Dis. 2010 Feb;20(2):140-6. doi: 10.1016/j.numecd.2009.08.006. Epub 2009 Oct 14. Review.

PMID:
19833491
9.

Targeting vascular risk in patients with metabolic syndrome but without diabetes.

Athyros VG, Mikhailidis DP, Papageorgiou AA, Didangelos TP, Peletidou A, Kleta D, Karagiannis A, Kakafika AI, Tziomalos K, Elisaf M.

Metabolism. 2005 Aug;54(8):1065-74.

PMID:
16092057
10.

Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.

Lee SJ, Lee DW, Kim KS, Lee IK.

Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S81-92.

PMID:
11733113
11.

Ghrelin improves endothelial function in patients with metabolic syndrome.

Tesauro M, Schinzari F, Iantorno M, Rizza S, Melina D, Lauro D, Cardillo C.

Circulation. 2005 Nov 8;112(19):2986-92. Epub 2005 Oct 31.

12.

Reduction of blood cholesterol and ischemic injury in the hypercholesteromic rabbits with modified resveratrol, longevinex. [corrected]

Juhasz B, Das DK, Kertesz A, Juhasz A, Gesztelyi R, Varga B.

Mol Cell Biochem. 2011 Feb;348(1-2):199-203. doi: 10.1007/s11010-010-0615-2. Epub 2010 Nov 4. Erratum in: Mol Cell Biochem. 2011 Feb;348(1-2):205. Juhaz, Bela [corrected to Juhasz, Bela].

PMID:
21052791
13.

Endothelial function and arterial stiffness in normotensive normoglycemic first-degree relatives of diabetic patients are independent of the metabolic syndrome.

Scuteri A, Tesauro M, Rizza S, Iantorno M, Federici M, Lauro D, Campia U, Turriziani M, Fusco A, Cocciolillo G, Lauro R.

Nutr Metab Cardiovasc Dis. 2008 Jun;18(5):349-56. Epub 2007 Nov 1.

PMID:
17935958
14.

Allopurinol improves endothelial function and reduces oxidant-inflammatory enzyme of myeloperoxidase in metabolic syndrome.

Yiginer O, Ozcelik F, Inanc T, Aparci M, Ozmen N, Cingozbay BY, Kardesoglu E, Suleymanoglu S, Sener G, Cebeci BS.

Clin Res Cardiol. 2008 May;97(5):334-40. doi: 10.1007/s00392-007-0636-3. Epub 2007 Dec 28.

PMID:
18330493
15.

The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial dysfunction or insulin resistance--The Hoorn Study.

Henry RM, Ferreira I, Dekker JM, Nijpels G, Scheffer PG, Stehouwer CD.

J Hum Hypertens. 2009 Nov;23(11):718-27. doi: 10.1038/jhh.2009.8. Epub 2009 Mar 12.

PMID:
19279658
16.

Intensive practical lifestyle intervention improves endothelial function in metabolic syndrome independent of weight loss: a randomized controlled trial.

Seligman BG, Polanczyk CA, Santos AS, Foppa M, Junges M, Bonzanini L, Nicolaidis G, Camey S, Lopes AL, Sehl P, Duncan BB, Clausell N.

Metabolism. 2011 Dec;60(12):1736-40. doi: 10.1016/j.metabol.2011.05.006. Epub 2011 Jun 22.

17.
18.

Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome.

Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES.

Diabetes Care. 2003 Jul;26(7):2119-25.

PMID:
12832323
19.

High-intensity aerobic training improves endothelium-dependent vasodilation in patients with metabolic syndrome and type 2 diabetes mellitus.

da Silva CA, Ribeiro JP, Canto JC, da Silva RE, Silva Junior GB, Botura E, Malschitzky MA.

Diabetes Res Clin Pract. 2012 Feb;95(2):237-45. doi: 10.1016/j.diabres.2011.09.034. Epub 2011 Oct 29.

PMID:
22041126
20.

[Endothelial dysfunction and target organ damage in hypertensive patients complicating with or without metabolic syndrome].

Lin JX, Yang X, Zheng XY, Chen DG.

Zhonghua Xin Xue Guan Bing Za Zhi. 2007 Aug;35(8):710-4. Chinese.

PMID:
17963628
Items per page

Supplemental Content

Write to the Help Desk